Health Condition 1: B372- Candidiasis of skin and nail
Conditions
Interventions
Intervention1: Test Drug- Marham e Raal: Topical application of Marham on the affected part twice a day
Control Intervention1: Comparative Drug Ketoconazole 2% ointment: Topical application of ointmen
Sponsors
Department of Amraz e Jild wa Zohrawiya
Eligibility
Inclusion criteria
Inclusion criteria: All the patients of candida intertrigo confirmed clinically by examination. Patients of controlled T2DM Patients of all age group Patient of either sex. Patient willing to sign the written informed consent. Patient who follow the protocol. Patients of relapse.
Exclusion criteria
Exclusion criteria: Patient diagnosed with other skin ailments like psoriasis, eczema. Patients suffering from HTN, IHD, uncontrolled T2DM & HIV Patient who fail to give consent. Patient who fail to follow up. Subjects who fail to comply the study protocol or stop treatment midway during protocol will not be included in final data analysis but they will be reported separately.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement criteria for candida intertrigo based on visual confirmation of lesion reduction in extent and severity by photographic evaluation Assessment of safety by clinical examination and investigationsTimepoint: 7th, 14th, 21th, 28th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in erythema, itching, maceration, and burning Patient satisfaction and adverse event monitoringTimepoint: 7th, 14th, 21th, 28th day | — |
Countries
India
Contacts
Public ContactABDUL HADI
Ajmal Khan Tibbiya College, Faculty of Unani Medicine,ALIGARH MUSLIM UNIVERSITY, ALIGARH
Outcome results
None listed